<DOC>
	<DOCNO>NCT01198249</DOCNO>
	<brief_summary>This study aim evaluate pharmacokinetics drug-drug interaction among anti-hypertension drugs-amlodipine , losartan , hydrochlorothiazide . This pilot study provide useful information develop new fix dose combination drug .</brief_summary>
	<brief_title>Pharmacokinetic Drug Interactions Between Single Concomitant Administrations Amlodipine , Losartan , Hydrochlorothiazide Subjects With ( Pre ) Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Adult subject 2050 year age Above 55Kg within ±20 % ideal body weight Subjects average 130mmHg ≤ systolic blood pressure ( SBP ) &lt; 160mmHg , 80mmHg ≤ diastolic blood pressure ( DBP ) &lt; 100mmHg Female subject confirm nonpregnant status agree comply proper contraception . Subjects write informed consent Subjects suspect acute disease Subjects past history may affect drug absorption , distribution , metabolism elimination Subjects gastrointestinal history Subjects whose heartrate le 60 Subject suspect orthostatic hypotension Subjects clinically significant allergy disease Subject currently participate participate study investigational compound device within 30 day sign informed consent Administration prescription drug within 14 day counter ( OTC ) drug within 7 day Subjects past history drug abuse positive drug screen test Subjects donate whole blood within 60 day platelet within 30days . Subjects take St John 's wort CYP inhibitor inducer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>